Prospective and multicentre study of radiofrequency treatment in anal fistula.
Crohn's disease
anal incontinence
fistula-in-ano
radiofrequency
sphincter-sparing
Journal
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
revised:
04
09
2022
received:
11
04
2022
accepted:
06
09
2022
pubmed:
22
9
2022
medline:
25
2
2023
entrez:
21
9
2022
Statut:
ppublish
Résumé
The most effective treatment for anal fistula is fistulotomy, but it involves a risk of anal incontinence. To reduce this morbidity, sphincter-sparing treatments have been developed, but their success in real life is often less than 50%. The aim is to determine the clinical healing rate 6 months after radiofrequency treatment. We planned to evaluate 50 patients from three French proctology centres. Treatment efficacy was evaluated at 6 and 12 months by means of clinical and magnetic resonance imaging examination. We evaluated morbidity and healing prognostic factors. Fifty patients with a mean age of 51 years (22-82) were included. Eleven patients had a low trans-sphincteric fistula (LTS), 21 patients had a high trans-sphincteric fistula (HTS), eight had a complex fistula and nine had Crohn's disease fistula. After 6 months, 17 patients (34.7%) had a clinically healed fistula, including five (45.5%) with LTS fistula, seven (33.3%) with HTS fistula, one (12.5%) with complex fistula, four (44.4%) with Crohn's disease, with no significant difference between these fistula types (p: 0.142). At 12 months, the healing rate was identical. MRI in 15 out of 17 clinically healed patients showed a deep remission of 73.3% at 12 months. Energy power was associated with the success of the treatment. There was an 8.2% incidence of post-surgical complications with 4.1% being abscesses (one required surgical management). Postoperative pain was minor. No new cases or deterioration of continence have been shown. Radiofrequency is effective in 34.7% of the cases as an anal fistula treatment in this first prospective study, with low morbidity and no effect on continence. Clinical healing was deep (MRI) in three-quarters at 1 year. The increase in energy power during the procedure seems to be a key point to be analysed to optimise results.
Sections du résumé
BACKGROUND
The most effective treatment for anal fistula is fistulotomy, but it involves a risk of anal incontinence. To reduce this morbidity, sphincter-sparing treatments have been developed, but their success in real life is often less than 50%. The aim is to determine the clinical healing rate 6 months after radiofrequency treatment.
METHODS
We planned to evaluate 50 patients from three French proctology centres. Treatment efficacy was evaluated at 6 and 12 months by means of clinical and magnetic resonance imaging examination. We evaluated morbidity and healing prognostic factors.
RESULTS
Fifty patients with a mean age of 51 years (22-82) were included. Eleven patients had a low trans-sphincteric fistula (LTS), 21 patients had a high trans-sphincteric fistula (HTS), eight had a complex fistula and nine had Crohn's disease fistula. After 6 months, 17 patients (34.7%) had a clinically healed fistula, including five (45.5%) with LTS fistula, seven (33.3%) with HTS fistula, one (12.5%) with complex fistula, four (44.4%) with Crohn's disease, with no significant difference between these fistula types (p: 0.142). At 12 months, the healing rate was identical. MRI in 15 out of 17 clinically healed patients showed a deep remission of 73.3% at 12 months. Energy power was associated with the success of the treatment. There was an 8.2% incidence of post-surgical complications with 4.1% being abscesses (one required surgical management). Postoperative pain was minor. No new cases or deterioration of continence have been shown.
CONCLUSION
Radiofrequency is effective in 34.7% of the cases as an anal fistula treatment in this first prospective study, with low morbidity and no effect on continence. Clinical healing was deep (MRI) in three-quarters at 1 year. The increase in energy power during the procedure seems to be a key point to be analysed to optimise results.
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
289-297Informations de copyright
© 2022 Association of Coloproctology of Great Britain and Ireland.
Références
Hyman N, O'Brien S, Osler T. Outcomes after fistulotomy: results of a prospective, multicenter regional study. Dis Colon Rectum. 2009;52(12):2022-7.
Steele SR, Kumar R, Feingold DL, Rafferty JL, Buie WD. Standards practice task force of the American Society of Colon and Rectal Surgeons. Practice parameters for the management of perianal abscess and fistula-in-ano. Dis Colon Rectum. 2011;54(12):1465-74.
Jordán J, Roig JV, García-Armengol J, García-Granero E, Solana A, Lledó S. Risk factors for recurrence and incontinence after anal fistula surgery. Colorectal Dis. 2010;12(3):254-60.
Abramowitz L, Soudan D, Souffran M, Bouchard D, Castinel A, Suduca JM, et al. The outcome of fistulotomy for anal fistula at 1 year: a prospective multicentre French study. Colorectal Dis. 2016;18(3):279-85.
Pearl RK, Andrews JR, Orsay CP, Weisman RI, Prasad ML, Nelson RL, et al. Role of the seton in the management of anorectal fistulas. Dis Colon Rectum. 1993;36(6):573-7. discussion 577-579.
Blumetti J, Abcarian A, Quinteros F, Chaudhry V, Prasad L, Abcarian H. Evolution of treatment of fistula in ano. World J Surg. 2012;36(5):1162-7.
Abramowitz L, Allez M, Devulder F, Faucheron JL, Ganansia R, Soudan D, et al. Guide pratique d'utilisation des colles de fibrines dans les fistules anales. Paris: Springer; 2010 (Collection SNFCP, en partenariat avec le GETAID et le CREGG).
Damon H, Guye O, Seigneurin A, Long F, Sonko A, Faucheron JL, et al. Prevalence of anal incontinence in adults and impact on quality-of-life. Gastroenterol Clin Biol. 2006;30(1):37-43.
Amato A, Bottini C, De Nardi P, Giamundo P, Lauretta A, Realis Luc A, et al. Evaluation and management of perianal abscess and anal fistula: SICCR position statement. Tech Coloproctol. 2020;24(2):127-43.
Garcia-Aguilar J, Belmonte C, Wong WD, Goldberg SM, Madoff RD. Anal fistula surgery. Factors associated with recurrence and incontinence. Dis Colon Rectum. 1996;39(7):723-9.
Lunniss PJ, Kamm MA, Phillips RK. Factors affecting continence after surgery for anal fistula. Br J Surg. 1994;81(9):1382-5.
Emile SH, Elfeki H, Thabet W, Sakr A, Magdy A, El-Hamed TMA, et al. Predictive factors for recurrence of high transsphincteric anal fistula after placement of seton. J Surg Res. 2017;213:261-8.
Cirocchi R, Santoro A, Trastulli S, Farinella E, Di Rocco G, Vendettuali D, et al. Meta-analysis of fibrin glue versus surgery for treatment of fistula-in-ano. Ann Ital Chir. 2010;81(5):349-56.
Williams JG, MacLeod CA, Rothenberger DA, Goldberg SM. Seton treatment of high anal fistulae. Br J Surg. 1991;78(10):1159-61.
Ommer A, Herold A, Berg E, Fürst A, Post S, Ruppert R, et al. German S3 guidelines: anal abscess and fistula (second revised version). Langenbecks Arch Surg. 2017;402(2):191-201.
Stellingwerf ME, van Praag EM, Tozer PJ, Bemelman WA, Buskens CJ. Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn's high perianal fistulas. BJS Open. 2019;3(3):231-41.
de Parades V, Far HS, Etienney I, Zeitoun JD, Atienza P, Bauer P. Seton drainage and fibrin glue injection for complex anal fistulas. Colorectal Dis. 2010;12(5):459-63.
Bubbers E, Cologne K. Management of Complex Anal Fistulas. Clin Colon Rectal Surg. 2016;29(1):43-9.
Bleier JIS, Moloo H, Goldberg SM. Ligation of the intersphincteric fistula tract: an effective new technique for complex fistulas. Dis Colon Rectum. 2010;53(1):43-9.
Terzi MC, Agalar C, Habip S, Canda AE, Arslan NC, Obuz F. Closing perianal fistulas using a laser: long-term results in 103 patients. Dis Colon Rectum. 2018;61(5):599-603.
Wilhelm A, Fiebig A, Krawczak M. Five years of experience with the FiLaC™ laser for fistula-in-ano management: long-term follow-up from a single institution. Tech Coloproctol. 2017;21(4):269-76.
Garg P, Singh P. Video-assisted anal fistula treatment (VAAFT) in cryptoglandular fistula-in-ano: a systematic review and proportional meta-analysis. Int J Surg. 2017;46:85-91.
Lohsiriwat V, Yodying H, Lohsiriwat D. Incidence and factors influencing the development of fistula-in-ano after incision and drainage of perianal abscesses. J Med Assoc Thai. 2010;93(1):61-5.
Bouchard D. Recommandations pour la pratique clinique des lesions ano-perineales de la maladie de crohn.
Eddama MMR, Everson M, Renshaw S, Taj T, Boulton R, Crosbie J, et al. Radiofrequency ablation for the treatment of haemorrhoidal disease: a minimally invasive and effective treatment modality. Tech Coloproctol. 2019;23(8):769-74.
Casana R, Tolva VS, Odero A, Malloggi C, Parati G. Three-year follow-up and quality of life of endovenous radiofrequency ablation of the great saphenous vein with the ClosureFast™ procedure: influence of BMI and CEAP class. Vascular. 2018;26(5):498-508.
Spiliopoulos S, Theodosiadou V, Sotiriadi A, Karnabatidis D. Endovenous ablation of incompetent truncal veins and their perforators with a new radiofrequency system. Mid-Term Outcomes Vascular. 2015;23(6):592-8.
Gupta PJ. Radiosurgical fistulotomy; an alternative to conventional procedure in fistula in ano. Curr Surg. 2003;60(5):524-8.
Filingeri V, Gravante G, Cassisa D. Clinical applications of radiofrequency in proctology: a review. Eur Rev Med Pharmacol Sci. 2006;10(2):79-85.
Xiarchos A, Tshijanu F, Tsakpini A. Endoscopic radiofrequency ablation of fistula in Ano (E-RaFisTura) in the era of surgical innovation. A serial prospective evaluation of 10 patients. Gastroint Hepatol Dig Dis. 2021;4(1):1-3. Disponible sur. http://scivisionpub.com/pdfs/endoscopic-radiofrequency-ablation-of-fistula-in-ano-erafistura-in-the-era-of-surgical-innovation-a-serial-prospective-evaluation--1978.pdf
Vaizey CJ, Carapeti E, Cahill JA, Kamm MA. Prospective comparison of faecal incontinence grading systems. Gut. 1999;44(1):77-80.
Merlini l'Héritier A, Siproudhis L, Bessi G, Le Balc'h E, Wallenhorst T, Bouguen G, et al. Sphincter-sparing surgery for complex anal fistulas: radiofrequency thermocoagulation of the tract is of no help. Colorectal Dis. 2019;21(8):961-6.
de Groof EJ, Sahami S, Lucas C, Ponsioen CY, Bemelman WA, Buskens CJ. Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment. Colorectal Dis. 2016;18(7):667-75.
Williams G, Williams A, Tozer P, Phillips R, Ahmad A, Jayne D, et al. The treatment of anal fistula: second ACPGBI position statement - 2018. Colorectal Dis. 2018;20(S3):5-31.
Giamundo P, Geraci M, Tibaldi L, Valente M. Closure of fistula-in-ano with laser-FiLaC™: an effective novel sphincter-saving procedure for complex disease. Colorectal Dis. 2014;16(2):110-5.
Giamundo P, Esercizio L, Geraci M, Tibaldi L, Valente M. Fistula-tract laser closure (FiLaC™): long-term results and new operative strategies. Tech Coloproctol. 2015;19(8):449-53.
Lauretta A, Falco N, Stocco E, Bellomo R, Infantino A. Anal fistula laser closure: the length of fistula is the Achilles' heel. Tech Coloproctol. 2018;22(12):933-9.
Isik O, Gulcu B, Ozturk E. Long-term outcomes of laser ablation of fistula tract for fistula-in-Ano: a considerable option in sphincter preservation. Dis Colon Rectum. 2020;63(6):831-6.
Marref I, Spindler L, Aubert M, Lemarchand N, Fathallah N, Pommaret E, et al. The optimal indication for FiLaC® is high trans-sphincteric fistula-in-ano: a prospective cohort of 69 consecutive patients. Tech Coloproctol. 2019;23(9):893-7.
Garcia-Granero A, Granero-Castro P, Frasson M, Flor-Lorente B, Carreño O, Espí A, et al. Management of cryptoglandular supralevator abscesses in the magnetic resonance imaging era: a case series. Int J Colorectal Dis. 2014;29(12):1557-64.
Frountzas M, Stergios K, Nikolaou C, Bellos I, Schizas D, Linardoutsos D, et al. Could FiLaC™ be effective in the treatment of anal fistulas? A systematic review of observational studies and proportional meta-analysis. Colorectal Dis. 2020;22(12):1874-84.
Elfeki H, Shalaby M, Emile SH, Sakr A, Mikael M, Lundby L. A systematic review and meta-analysis of the safety and efficacy of fistula laser closure. Tech Coloproctol. 2020;24(4):265-74.
Witte ME, Klaase JM, Gerritsen JJGM, Kummer EW. Fibrin glue treatment for simple and complex anal fistulas. Hepatogastroenterology. 2007;54(76):1071-3.